Licensing deals morph to acquisitions in seller's market

被引:0
作者
Nuala Moran
机构
来源
Nature Biotechnology | 2007年 / 25卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Pharma's pipeline problems, coupled with the trend toward acquisition, are giving biotechs more leverage in licensing discussions.
引用
收藏
页码:609 / 610
页数:1
相关论文
共 50 条
[31]   Notable licensing deals in the biopharma industry in the second quarter of 2017 [J].
D'Souza, P. .
DRUGS OF TODAY, 2017, 53 (08) :453-458
[32]   Analysis of China-to-West pharmaceutical licensing deals in 2024 [J].
Tang, Leon 'Jun' .
NATURE REVIEWS DRUG DISCOVERY, 2025, 24 (06) :411-412
[33]   Notable licensing deals in the biopharma industry in the third quarter of 2017 [J].
D'Souza, P. .
DRUGS OF TODAY, 2017, 53 (10) :553-557
[34]   Licensing the market for technology [J].
Arora, A ;
Fosfuri, A .
JOURNAL OF ECONOMIC BEHAVIOR & ORGANIZATION, 2003, 52 (02) :277-295
[35]   Valuation and design of pharmaceutical R&D licensing deals [J].
Rogers, MJ ;
Maranas, CD ;
Ding, M .
AICHE JOURNAL, 2005, 51 (01) :198-209
[36]   ASSOCIATION BETWEEN MARKET PRICE AND SELLER MARKET CHARACTERISTICS [J].
GEISTFELD, LV ;
KEY, RJ .
JOURNAL OF CONSUMER AFFAIRS, 1991, 25 (01) :57-67
[38]   Acquisitions take off in 2010, but deals still face hurdles [J].
Rubin, Debra K. .
ENR (Engineering News-Record), 2010, 264 (03)
[39]   Social Media's Impact on the Global Mergers and Acquisitions Market [J].
Jayasuriya, Dulani ;
O'Neill, Ben .
JOURNAL OF RISK AND FINANCIAL MANAGEMENT, 2021, 14 (04)
[40]   THE STATE AS A SELLER OF RESOURCES IN THE FINANCIAL MARKET [J].
Isaieva, O., V .
FINANCIAL AND CREDIT ACTIVITY-PROBLEMS OF THEORY AND PRACTICE, 2012, 2 (13) :276-282